HK219796A - Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the HIV-2 type and antigens presenting with them an immunological relationship - Google Patents

Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the HIV-2 type and antigens presenting with them an immunological relationship

Info

Publication number
HK219796A
HK219796A HK219796A HK219796A HK219796A HK 219796 A HK219796 A HK 219796A HK 219796 A HK219796 A HK 219796A HK 219796 A HK219796 A HK 219796A HK 219796 A HK219796 A HK 219796A
Authority
HK
Hong Kong
Prior art keywords
glycoprotein
type
hiv
antigenes
transmembrane glycoprotein
Prior art date
Application number
HK219796A
Other languages
English (en)
Inventor
Ara Hovanessian
Maire-Anne Rey
Anne Laurent
Bernard Krust
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8906322A external-priority patent/FR2646854A1/fr
Priority claimed from US07/356,459 external-priority patent/US5208321A/en
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of HK219796A publication Critical patent/HK219796A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK219796A 1989-05-12 1996-12-24 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the HIV-2 type and antigens presenting with them an immunological relationship HK219796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8906322A FR2646854A1 (fr) 1989-05-12 1989-05-12 Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 antigenes presentant avec eux une parente immunologique
US07/356,459 US5208321A (en) 1988-06-09 1989-05-25 HIV-2 transmembrane glycoprotein homodimer (GP 80)
PCT/FR1990/000336 WO1990013314A2 (fr) 1989-05-12 1990-05-11 Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 (antigenes presentant avec eux une parente immunologique)

Publications (1)

Publication Number Publication Date
HK219796A true HK219796A (en) 1997-01-03

Family

ID=26227325

Family Applications (1)

Application Number Title Priority Date Filing Date
HK219796A HK219796A (en) 1989-05-12 1996-12-24 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the HIV-2 type and antigens presenting with them an immunological relationship

Country Status (11)

Country Link
EP (1) EP0424519B1 (xx)
JP (5) JP3534746B2 (xx)
AT (1) ATE136789T1 (xx)
CA (1) CA2032505C (xx)
DE (1) DE69026569T2 (xx)
DK (1) DK0424519T3 (xx)
ES (1) ES2085908T3 (xx)
HK (1) HK219796A (xx)
OA (1) OA09634A (xx)
SG (1) SG48125A1 (xx)
WO (1) WO1990013314A2 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256561A (en) * 1991-12-20 1993-10-26 Abbott Laboratories Monoclonal antibody to HIV-2 and uses thereof
FR2692898B1 (fr) * 1992-06-30 1995-06-02 Centre Nat Rech Scient Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination.
JP2013040148A (ja) * 2011-08-19 2013-02-28 Asahi Kasei Corp シアリルオリゴ糖ペプチド固定化ビーズ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE47725T1 (de) * 1986-01-22 1989-11-15 Pasteur Institut Zum hervorrufen von aids geeigneter retrovirus vom typ hiv-2, sowie seine antigen- und nukleinsaeure-bestandteile.
EP0269520A3 (fr) * 1986-11-21 1988-08-24 Institut Pasteur Rétrovirus du type HIV-2 susceptible de provoquer le sida, et ses constituants antigéniques et nucléiques
WO1988005440A1 (fr) * 1987-01-16 1988-07-28 Institut Pasteur Peptides ayant des proprietes immunologiques 2-hiv-2
FR2620030B1 (fr) * 1987-09-07 1990-03-23 Transgene Sa Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus

Also Published As

Publication number Publication date
JP2003146999A (ja) 2003-05-21
ES2085908T3 (es) 1996-06-16
DK0424519T3 (da) 1996-05-13
OA09634A (fr) 1993-04-30
SG48125A1 (en) 1998-04-17
ATE136789T1 (de) 1996-05-15
WO1990013314A2 (fr) 1990-11-15
JP2005170949A (ja) 2005-06-30
JP4174591B2 (ja) 2008-11-05
CA2032505C (fr) 2001-07-10
WO1990013314A3 (fr) 1990-12-27
JP3534746B2 (ja) 2004-06-07
JPH03506042A (ja) 1991-12-26
CA2032505A1 (fr) 1990-11-13
JP3833681B2 (ja) 2006-10-18
EP0424519A1 (fr) 1991-05-02
EP0424519B1 (fr) 1996-04-17
DE69026569T2 (de) 1996-09-05
JP2008156350A (ja) 2008-07-10
DE69026569D1 (de) 1996-05-23
JP4423374B2 (ja) 2010-03-03
JP2006213702A (ja) 2006-08-17

Similar Documents

Publication Publication Date Title
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
ATE64601T1 (de) Lymphadenopathie-assoziierte huellenantigene und deren verwendungen.
EP1630229A3 (en) Melanoma antigens
NZ219113A (en) Hiv peptide containing epitope of the env protein
DE3855947D1 (de) Peptide mit den immunologischen Eigenschaften von HIV-2
WO1991004273A3 (en) Novel peptides associated with the cd4 binding region of gp120 and their methods of use
CA2091263A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
HK219796A (en) Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the HIV-2 type and antigens presenting with them an immunological relationship
AU8010791A (en) Hiv monoclonal antibody
WO1989009227A3 (fr) Peptides pf10 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic
EP0250128A3 (en) Novel virus isolated from patients with aids
GR3026310T3 (en) Proteins and glycoproteins of the HIV-2 EHO retrovirus antibodies direced against them - application for the diagnosis.
HK167295A (en) Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)